跳至主要内容
临床试验/NCT04783701
NCT04783701招募中不适用

Coronary CT Angio Evaluating Graft Patency in ACS Patients Treated With DAPT or Single ASA After CABG (CoCAP)

University Hospital, Linkoeping6 个研究点 分布在 2 个国家目标入组 360 人开始时间: 2021年5月17日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
360
试验地点
6
主要终点
Graft patency after CABG

研究概览

简要总结

The purpose of this study is to compare the presence of graft patency in single aspirin vs dual anti platelet therapy (DAPT) treatment including ticagrelor in patients with acute coronary syndrome (ACS) treated with coronary artery bypass surgery (CABG). Follow up time is 12-36 months postoperatively and the patency will be evaluated with coronary computed tomography angiography (CCTA)

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Previously included in TACSI-trial

排除标准

  • Highly irregular heart rhythm (i.e. atrial fibrillation)
  • Chronic kidney disease with estimated glomerular filtration rate (eGFR) <45ml/min/1,73m2
  • Body weight >120 kg
  • Previous severe allergic reaction (i.e. anaphylactic reaction) to iodine-based contrast agents
  • Not able to communicate
  • Not willing to participate

结局指标

主要结局

Graft patency after CABG

时间窗: 12-36 months

Defined as patency on CCTA (FitzGibbon A) without previous graft failure identified on CCTA and/or invasive coronary angio (ICA) since CABG, intention to treat (ITT) analysis.

次要结局

  • Graft patency after CABG(12-36 months)
  • Graft patency after CABG - PP analysis(12-36 months)

研究者

发起方
University Hospital, Linkoeping
申办方类型
Other
责任方
Principal Investigator
主要研究者

Jonas Holm

MD, PhD

University Hospital, Linkoeping

研究点 (6)

Loading locations...

相似试验

Coronary CT Angio Evaluating Graft Patency in ACS... | 临床试验